Business
Neuren FDA meeting confirms Phase 3 plan for Rett syndrome
Neuren FDA meeting confirms Phase 3 plan for Rett syndrome
About this update from Neuren Pharmaceuticals Limited
[{"type":"text","content":"Neuren Pharmaceuticals Ltd has released a press release. View Attachment","length":255,"tagName":"div"}]